FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical compositions containing a GLP-1 agonist and an N-(8-(2-hydroxybenzoyl)amino)caprylic acid salt.
EFFECT: development of methods of preparing pharmaceutical compositions containing a GLP-1 agonist and an N-(8-(2-hydroxybenzoyl)amino)caprylic acid salts and their use in medicine.
13 cl, 4 tbl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID SALT AND LUBRICANT | 2019 |
|
RU2807183C2 |
SOLID COMPOSITIONS CONTAINING AGONIST TO GLP AND SALT OF N-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | 2011 |
|
RU2600440C2 |
GLP-1 PEPTIDES COMPOSITIONS AND THEIR PRODUCTION | 2013 |
|
RU2641198C2 |
ORAL DOSING OF GLUCAGON-LIKE PEPTIDE-1 COMPOUNDS | 2014 |
|
RU2671406C2 |
SOLID COMPOSITIONS FOR ORAL ADMINISTRATION | 2018 |
|
RU2777206C2 |
DIPEPTIDE, CONTAINING NONPROTEINOGENIC AMINO ACID | 2012 |
|
RU2643515C2 |
DOUBLE-ACYLATED GLP-1 DERIVATIVES | 2010 |
|
RU2559540C2 |
NOVEL GLUCAGON ANALOGUES | 2012 |
|
RU2610175C2 |
GLUCAGON-LIKE PEPTIDE-1 (GLP-1) DERIVATIVES | 2004 |
|
RU2401276C2 |
ACYLATED GLP-1 COMPOUNDS | 2006 |
|
RU2434019C2 |
Authors
Dates
2023-09-27—Published
2019-05-06—Filed